130 related articles for article (PubMed ID: 38490404)
1. Exploring the immunomodulatory properties of glucan particles in human primary cells.
Jesus S; Panão Costa J; Colaço M; Lebre F; Mateus D; Sebastião AI; Cruz MT; Alfaro-Moreno E; Borges O
Int J Pharm; 2024 Apr; 655():123996. PubMed ID: 38490404
[TBL] [Abstract][Full Text] [Related]
2. Glucan Particles: Choosing the Appropriate Size to Use as a Vaccine Adjuvant.
Colaço M; Panão Costa J; Borges O
Methods Mol Biol; 2022; 2412():269-280. PubMed ID: 34918250
[TBL] [Abstract][Full Text] [Related]
3. Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen.
Soares E; Jesus S; Borges O
Eur J Pharm Biopharm; 2018 Oct; 131():33-43. PubMed ID: 30048745
[TBL] [Abstract][Full Text] [Related]
4. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.
Soares E; Groothuismink ZMA; Boonstra A; Borges O
Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
6. Beta-Glucan Particles as Vaccine Adjuvant Carriers.
Mirza Z; Soto ER; Dikengil F; Levitz SM; Ostroff GR
Methods Mol Biol; 2017; 1625():143-157. PubMed ID: 28584989
[TBL] [Abstract][Full Text] [Related]
7. Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen.
Donadei A; Gallorini S; Berti F; O'Hagan DT; Adamo R; Baudner BC
Mol Pharm; 2015 May; 12(5):1662-72. PubMed ID: 25867449
[TBL] [Abstract][Full Text] [Related]
8. Duality of β-glucan microparticles: antigen carrier and immunostimulants.
Baert K; De Geest BG; De Greve H; Cox E; Devriendt B
Int J Nanomedicine; 2016; 11():2463-9. PubMed ID: 27330289
[TBL] [Abstract][Full Text] [Related]
9. Robust Immune Responses Elicited by a Hybrid Adjuvant Based on β-Glucan Particles from Yeast for the Hepatitis B Vaccine.
Liu H; Meng Z; Wang H; Zhang S; Huang Z; Geng X; Guo R; Wu Z; Hong Z
ACS Appl Bio Mater; 2021 Apr; 4(4):3614-3622. PubMed ID: 35014447
[TBL] [Abstract][Full Text] [Related]
10. Beta-glucan's varying structure characteristics modulate survival and immune-related genes expression from Vibrio harveyi-infected Artemia franciscana in gnotobiotic conditions.
Han B; Baruah K; Nguyen DV; Williams DL; Devriendt B; Cox E; Bossier P
Fish Shellfish Immunol; 2020 Jul; 102():307-315. PubMed ID: 32371255
[TBL] [Abstract][Full Text] [Related]
11. Varying effects of different β-glucans on the maturation of porcine monocyte-derived dendritic cells.
Sonck E; Devriendt B; Goddeeris B; Cox E
Clin Vaccine Immunol; 2011 Sep; 18(9):1441-6. PubMed ID: 21752950
[TBL] [Abstract][Full Text] [Related]
12. Glucans and applications in drug delivery.
Lin H; Han R; Wu W
Carbohydr Polym; 2024 May; 332():121904. PubMed ID: 38431411
[TBL] [Abstract][Full Text] [Related]
13. Safe-by-Design of Glucan Nanoparticles: Size Matters When Assessing the Immunotoxicity.
Colaço M; Marques AP; Jesus S; Duarte A; Borges O
Chem Res Toxicol; 2020 Apr; 33(4):915-932. PubMed ID: 32138518
[TBL] [Abstract][Full Text] [Related]
14. Soluble β-glucan from Grifola frondosa induces proliferation and Dectin-1/Syk signaling in resident macrophages via the GM-CSF autocrine pathway.
Masuda Y; Togo T; Mizuno S; Konishi M; Nanba H
J Leukoc Biol; 2012 Apr; 91(4):547-56. PubMed ID: 22028332
[TBL] [Abstract][Full Text] [Related]
15. Microbial exopolysaccharides-β-glucans-as promising postbiotic candidates in vaccine adjuvants.
Abbasi A; Rahbar Saadat T; Rahbar Saadat Y
Int J Biol Macromol; 2022 Dec; 223(Pt A):346-361. PubMed ID: 36347372
[TBL] [Abstract][Full Text] [Related]
16. β-Glucan Grafted Microcapsule, a Tool for Studying the Immunomodulatory Effect of Microbial Cell Wall Polysaccharides.
Bouchemal K; Wong SSW; Huang N; Willment JA; Latgé JP; Aimanianda V
Bioconjug Chem; 2019 Jun; 30(6):1788-1797. PubMed ID: 31125199
[TBL] [Abstract][Full Text] [Related]
17. The effect of beta-glucans on porcine leukocytes.
Sonck E; Stuyven E; Goddeeris B; Cox E
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):199-207. PubMed ID: 20034677
[TBL] [Abstract][Full Text] [Related]
18. Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3).
Michalek M; Melican D; Brunke-Reese D; Langevin M; Lemerise K; Galbraith W; Patchen M; Mackin W
J Leukoc Biol; 1998 Sep; 64(3):337-44. PubMed ID: 9738660
[TBL] [Abstract][Full Text] [Related]
19. β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs.
Paris S; Chapat L; Martin-Cagnon N; Durand PY; Piney L; Cariou C; Bergamo P; Bonnet JM; Poulet H; Freyburger L; De Luca K
Front Immunol; 2020; 11():564497. PubMed ID: 33162977
[TBL] [Abstract][Full Text] [Related]
20. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]